The fears, the facts, and what an honest conversation with your psychiatrist should actually cover.
If you’ve ever sat across from a clinician who suggested medication for anxiety, you probably know the particular silence that follows.
Not a refusal, necessarily. More of a pause. A quiet cataloguing of concerns that didn’t quite make it into words. Will I become dependent on this? Will it change who I am? What happens if I want to stop? Am I going to feel like a dulled version of myself? Is this admitting that I can’t handle things on my own?
Those questions are real, they’re reasonable, and they deserve genuine answers — not reassurances designed to move the appointment along. Anxiety medication is one of the most prescribed categories in psychiatry and one of the least honestly discussed. What follows is an attempt to fix that.
First: there’s no single “anxiety medication”
One of the reasons the conversation gets confused is that “anxiety medication” isn’t a category in the way “antibiotic” is. It’s a loose umbrella covering several classes of medications that work through different mechanisms, have different timelines, carry different risks, and suit different situations.
Understanding the basic landscape makes the conversation with your clinician much more productive.
SSRIs and SNRIs are the most commonly prescribed first-line medications for anxiety disorders. These include medications like sertraline, escitalopram, venlafaxine, and duloxetine. Despite being called antidepressants, they’re as effective for anxiety as they are for depression — often more so for certain conditions. They take several weeks to build to their full effect, they’re not habit-forming, and they’re generally the right starting point for generalized anxiety, panic disorder, social anxiety, and OCD.
Buspirone is a non-habit-forming anti-anxiety medication that works specifically for generalized anxiety. It’s not sedating, doesn’t cause dependence, and is underused — partly because it takes two to four weeks to work and doesn’t produce an immediate effect that confirms it’s doing something.
Beta-blockers like propranolol don’t treat anxiety as a condition, but they blunt the physical symptoms of anxiety — the racing heart, the shaking hands, the flushed face — in specific, predictable situations. A musician before a performance. A physician before a difficult conversation. They’re situational tools, not ongoing treatment.
Benzodiazepines — including medications like lorazepam, clonazepam, and alprazolam (Xanax or Bars) — are the medications most people picture when they think of “anxiety medication,” and the ones that carry the most complex risk profile. They work quickly and reliably. They’re also habit-forming, they lose effectiveness over time as tolerance develops, they can impair cognition and coordination, and stopping them after regular use requires a careful taper. They have legitimate uses — short-term, situational, or bridging while another medication builds — but long-term daily benzodiazepine use for anxiety is increasingly recognized as a problematic default rather than good care.
Hydroxyzine is an antihistamine with anxiety-reducing effects. Non-habit-forming, works within an hour, and useful for acute anxiety episodes or sleep. Sedation is the main side effect. It’s a reasonable option for situational anxiety and for patients who want a non-benzodiazepine option for acute moments.
The dependency question
This is the fear that comes up most often, and it’s worth separating into two distinct concerns that often get conflated.
Physical dependence means the body has adapted to a medication and will produce discontinuation symptoms if it’s stopped abruptly. SSRIs and SNRIs can cause discontinuation syndrome — dizziness, flu-like symptoms, brain zaps — if stopped suddenly, particularly after long-term use. This is managed with a gradual taper. It’s a real consideration, but it’s not the same as addiction.
Addiction — the compulsive use of a substance despite harm, with craving, loss of control, and continued use despite negative consequences — is not what happens with SSRIs and SNRIs. They don’t produce euphoria. People don’t escalate the dose in pursuit of a high. They don’t crave them between doses.
Benzodiazepines are a more complicated picture. They do produce tolerance, they carry a real dependence risk with regular use, and stopping them after long-term daily use can be genuinely difficult. This doesn’t mean they’re never appropriate — it means they should be used with specific intention and a clear plan, not as an indefinite default.
The cleanest version of this distinction: most anxiety medications require thoughtful management when stopping, but only benzodiazepines carry a meaningful risk of what we’d clinically call addiction.
Will it change who I am?
This question usually carries more weight than it lets on. What people are really asking is: will I still be me? Will I lose the intensity, the drive, the sensitivity that I’ve always had? Will I become flat, compliant, unmoved by things that should move me?|
The honest answer is that for the medications most commonly used for anxiety — SSRIs, SNRIs, buspirone — personality change in the way people fear is not what typically happens. What tends to change is the volume of the noise. The constant hum of worry that runs underneath everything. The physical tension. The hypervigilance. The way a small stressor can hijack an entire day.
What doesn’t change — when the medication is right and the dose is calibrated — is the fundamental texture of who you are. Your values, your humor, your relationships, your passions. People frequently report being more themselves on the right medication, not less. The version of them that was always there under the anxiety becomes more accessible.
That said, it’s worth naming that emotional blunting does happen, more often at higher doses or with certain medications. If you feel flatter, less able to access emotion in either direction, less interested in things you used to care about — that’s important clinical information, not something to push through. It usually means the dose needs adjusting or the medication isn’t the right fit.
What about the medication I’ve heard is addictive?
If a benzodiazepine has been suggested, it’s worth asking directly: why this, rather than something else? Is this for short-term use while something longer-acting builds? Is this for a specific situational use? Is the plan to reassess within weeks?
Those are reasonable questions and a good psychiatrist will welcome them. If the answer is vague, or if the implication is that this is simply what you’ll take going forward without a clear plan, that’s worth pushing on.
The goal of anxiety treatment — pharmacological or otherwise — is not to manage symptoms indefinitely with a medication that comes with increasing tolerance and difficult discontinuation. It’s to reduce anxiety enough that you can function well, engage in the other work of recovery (therapy, lifestyle, understanding the triggers), and eventually, in many cases, need less rather than more.
Why medication works best alongside therapy
This is one of the most consistent findings in anxiety treatment research, and it’s underemphasized in the busy short visit.
Medication reduces the intensity of anxiety. It lowers the volume enough that the cognitive and behavioral work becomes possible — the kind of work where you actually examine and change your relationship to anxious thought patterns, avoidance behaviors, and the triggers that sustain the anxiety cycle.
Without medication, therapy sometimes moves slowly because the anxiety itself interferes with the ability to engage. Sometimes, without therapy, medication often produces partial improvement that doesn’t last — because the underlying patterns that generate the anxiety are still intact, and the medication is managing symptoms rather than addressing causes.
The combination is consistently more effective than either alone for most anxiety disorders. That’s not an argument for always doing both. It’s an argument for not treating them as either-or.
The question about stopping
Most people want to know, before they start, what stopping looks like.
For SSRIs and SNRIs, stopping is managed with a gradual taper — slower at the lower doses, when the pharmacological impact of each reduction is proportionally larger. Done carefully, most people get through it without significant difficulty, though some people are more sensitive to discontinuation than others and need a slower approach.
The right time to consider stopping is generally after a sustained period of stability — typically at least six to twelve months for anxiety — and ideally not during a period of significant stress or life upheaval. The decision should be made with your prescriber, with a clear plan and clear criteria for what would prompt pausing or reversing course.
Stopping a medication and later deciding to restart it is not a failure. It’s information. Many people go on and off medications across different phases of their lives as circumstances change. That’s not a sign of weakness or of the medication not having worked. It’s a reasonable response to the way life actually unfolds.
What the visit should cover
If you’re about to have a conversation with a psychiatrist about medication for anxiety, a few questions worth raising:
What class of medication are you recommending, and why this one for my specific situation? The reasoning should be specific to you — your symptoms, your history, your concerns — not a generic first-line default.
What’s the realistic timeline? SSRIs take weeks. Buspirone takes weeks. If you’re expecting an immediate effect and the medication doesn’t work that way, you’ll think it isn’t working when it actually hasn’t had time to.
What side effects should I watch for, and which ones would change the plan? Early side effects — nausea, activation, sleep disruption — are common and often temporary. Knowing this in advance prevents people from stopping prematurely. Knowing which side effects warrant a call prevents people from suffering unnecessarily.
What’s the plan if this doesn’t work? A first medication trial doesn’t always produce the right response. Knowing there’s a next step before you need it makes the process less frightening.
If a benzodiazepine is on the table — what’s the specific plan for it? Duration, dose, how you’ll know when to reassess.
The takeaway
Anxiety medication is not a character flaw, a crutch, or a permanent surrender to a condition that should be conquerable by willpower alone. It’s a clinical tool with a good evidence base, real benefits, and real considerations that deserve honest discussion.
The fears most people carry into the conversation — dependence, personality change, being stuck on something forever — are worth naming out loud, because they have real, nuanced answers. Not dismissals. Answers.
The best version of this conversation leaves you understanding what you’re taking, why you’re taking it, what to expect, and what the plan is. If you haven’t had that version yet, it’s worth finding a clinician willing to have it.
Goldstone Psychiatry & Neuromodulation Center offers modern, personalized psychiatric care — including thoughtful, thorough medication management for anxiety and the conditions that accompany it. Telepsychiatry is also available throughout Texas.